Drug Shortage Report for AURO-CEFIXIME
Report ID | 166650 |
Drug Identification Number | 02468689 |
Brand name | AURO-CEFIXIME |
Common or Proper name | CEFIXIME |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFIXIME |
Strength(s) | 100MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 50ml |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-08-12 |
Estimated end date | 2023-09-01 |
Actual end date | 2023-07-31 |
Shortage status | Resolved |
Updated date | 2023-08-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2023-08-08 | French | Compare |
v22 | 2023-08-08 | English | Compare |
v21 | 2023-08-02 | French | Compare |
v20 | 2023-08-02 | English | Compare |
v19 | 2023-07-24 | French | Compare |
v18 | 2023-07-24 | English | Compare |
v17 | 2023-05-23 | French | Compare |
v16 | 2023-05-23 | English | Compare |
v15 | 2023-04-25 | French | Compare |
v14 | 2023-04-25 | English | Compare |
v13 | 2023-03-16 | French | Compare |
v12 | 2023-03-16 | English | Compare |
v11 | 2023-02-01 | French | Compare |
v10 | 2023-02-01 | English | Compare |
v9 | 2023-01-16 | French | Compare |
v8 | 2023-01-16 | English | Compare |
v7 | 2022-12-19 | French | Compare |
v6 | 2022-12-19 | English | Compare |
v5 | 2022-12-01 | French | Compare |
v4 | 2022-12-01 | English | Compare |